thiazolyl blue has been researched along with Diabetic Angiopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andelfinger, G; Balazy, M; Boisvert, C; Brault, S; Chemtob, S; d'Orleans-Juste, P; Falck, JR; Germain, S; Gobeil, F; Hardy, P; Jain, K; Kermorvant-Duchemin, E; Kooli, A; Ong, H; Sennlaub, F; Sirinyan, M; Zhu, T | 1 |
1 other study(ies) available for thiazolyl blue and Diabetic Angiopathies
| Article | Year |
|---|---|
Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration.
Topics: Animals; Apoptosis; Arachidonic Acids; Blotting, Western; Cell Survival; Cells, Cultured; Diabetic Angiopathies; DNA Primers; Endothelial Cells; Gene Expression Regulation; In Situ Nick-End Labeling; Neovascularization, Physiologic; Nitric Oxide; Rats; Rats, Sprague-Dawley; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; Sus scrofa; Tetrazolium Salts; Thiazoles; Thrombospondin 1 | 2005 |